Reported Reactions

Devices › Intraocular lens

Device brand name · Intraocular lens

Collamer Ultraviolet-Absorbing Posterior Chamber Three Piece Foldable Intraocula: medical device reports filed with FDA

603 reports name it, 2006–2013. Manufacturer given most often on reports: Staar Surgical. Product code HQL.

603
device reports naming the brand
0% of all MAUDE reports · about 30 a year
0
reports, 12 months to August 2026
0 in the 12 months before
65.3%
classified as malfunction
52.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

603 medical device reports received by FDA name the brand "Collamer Ultraviolet-Absorbing Posterior Chamber Three Piece Foldable Intraocula" (intraocular lens); the manufacturer given most often on reports is Staar Surgical; received from March 2006 to December 2013. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (65.3%), injury (21.9%) and other (12.6%); across all intraocular lens reports (product code HQL) death is recorded in 0% and malfunction in 52.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are lens (iol), torn, split, cracked (50.9%), haptic(s), broken (12.3%) and other (for use when an appropriate device code cannot be identified) (10%). The patient problems coded most often are surgical procedure, surgical incision, enlargement of and vitrectomy. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Collamer Ultraviolet-Absorbing Posterior Chamber Three Piece Foldable Intraocula was received in the five years to August 2026; the latest was received in December 2013.

By year received

0931852006: 420062007: 12820072008: 18520082009: 11820092010: 11920102011: 2220112012: 1520122013: 122013

Event type and report source

Event type, as classified on the report

Death0%0
Injury21.9%132
Malfunction65.3%394
Other12.6%76
Not given0.2%1

Who filed the report

Manufacturer report100%603
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 79,755 reports carrying product code HQL. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Lens (iol), torn, split, cracked30750.9%4.7%
Haptic(s), broken7412.3%2.7%
Other (for use when an appropriate device code cannot be identified)6010%2.2%
Lens damaged in delivery system447.3%0.8%
Haptic(s), bent305%3.1%
Haptic damaged in delivery system294.8%1%
Lens, stuck in cartridge101.7%0.4%
Explanted91.5%7.3%
Lens stuck in delivery system81.3%0.7%
Defective devicethe device was defective61%1.9%
Foreign material50.8%0.3%
Device remains implanted30.5%4.3%
Implant, removal of30.5%1%
Lens (iol), dislocated intraocular30.5%0.4%
Plunger override30.5%0.1%
Breakthe device broke20.3%9.8%
Device operates differently than expectedthe device behaved unexpectedly20.3%1%
Delivery system issue, no description10.2%0%
Device, removal of (non-implant)10.2%1%
Insufficient device problem information10.2%2.3%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Surgical procedure9615.9%
Surgical incision, enlargement of8914.8%
Vitrectomy193.2%
Capsular bag tear162.7%
Other (for use when an appropriate patient code cannot be identified)81.3%
Membrane, breakage of50.8%
Visual impairmentreduced vision30.5%
Halo20.3%
Loss of vision20.3%
No patient involvement20.3%
Abrasion10.2%
Bleeding10.2%
Blurred vision10.2%
Decreased va, distant (visual acuity)10.2%
Foreign body, removal of10.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureCollamer Ultraviolet-Absorbing Posterior Chamber Three Piece Foldable IntraoculaProduct code HQLAll MAUDE reports
Reports60379,75526,136,888
Share of that pool—0.8%0%
Classified as death, per 1,000 reports009
Classified as injury21.9%42.8%36.2%
Classified as malfunction65.3%52.8%62.3%
Filed by the manufacturer100%98.2%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code HQL

BrandReportsLatest 12 monthsClassified as death
Acrysof9,16100%
Tecnis Simplicity5,3101,2170%
Tecnis Iol5,9017150%
Tecnis3,08200.1%
Tecnis Itec Preloaded 1-Piece Iol2,43500%
AcrySof IQ Natural Singlepiece IOL2,4241180%
Clareon IOL with the AutonoME Delivery System2,2768640%
Tecnis 1-Piece2,25900%
enVista Intraocular Lens2,163360%
Hydroview Intraocular Lens2,06700%
Acrysof Restor3,80100%
Acrysof Iq Toric1,90500%
AcrySof Multipiece IOL1,6192980%
Silicone Advanced Optic-Violet Shield1,41300%
AcrySof Singlepiece IOL1,2111310%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Collamer Ultraviolet-Absorbing Posterior Chamber Three Piece Foldable Intraocula reports

How many FDA reports name Collamer Ultraviolet-Absorbing Posterior Chamber Three Piece Foldable Intraocula?

603 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (65.3%), injury (21.9%) and other (12.6%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

lens (iol), torn, split, cracked (50.9%), haptic(s), broken (12.3%), other (for use when an appropriate device code cannot be identified) (10%), lens damaged in delivery system (7.3%) and haptic(s), bent (5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Collamer Ultraviolet-Absorbing Posterior Chamber Three Piece Foldable Intraocula was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.